Valuation: Kenvue Inc.

Market Cap 36.44B 31.94B 29.52B 27.15B 51.23B 3,514B 52.06B 353B 138B 1,719B 137B 134B 5,924B P/E 2026 *
19.9x
P/E 2027 * 17.8x
Enterprise Value 43.85B 38.43B 35.53B 32.67B 61.65B 4,228B 62.64B 425B 167B 2,069B 165B 161B 7,128B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.7x
Free-Float
98.9%
Yield 2026 *
4.47%
Yield 2027 * 4.57%
1 day+0.18%
1 week-1.25%
Current month-0.63%
1 month+6.33%
3 months+8.02%
6 months+7.96%
Current year+10.09%
1 week 18.58
Extreme 18.58
19.36
1 month 17.86
Extreme 17.855
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
6/29/26 Free

Director

1,413 0.0001%
6/29/26
Starboard Value LP
OtherCompany 1,413 0.0001%
6/10/26 Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%-1.25%-14.19%-22.52% 36.44B
-0.71%+0.25%-4.06%-1.21% 349B
-0.73%+1.21%-6.75%+1.77% 135B
-0.72%-2.01%+5.42%+18.62% 74.4B
-0.19%-0.51%-14.05%-19.91% 52.31B
+1.36%+2.00%-3.80%-54.59% 29.71B
-0.53%+0.57%+15.00%+8.95% 19.89B
-0.50%+0.10%-26.44%-30.88% 19.85B
+0.70%+2.76%-1.17%+27.40% 18.43B
-0.66%-2.17%-14.90%+2.00% 11.39B
Average -0.25%+0.59%-6.49%-7.04% 74.7B
Weighted average by Cap. -0.55%+1.28%-4.97%-2.93%

Financials

2026 *2027 *
Net sales 15.63B 13.7B 12.66B 11.64B 21.97B 1,507B 22.32B 151B 59.34B 737B 58.67B 57.39B 2,540B 16.02B 14.04B 12.98B 11.94B 22.53B 1,545B 22.89B 155B 60.84B 756B 60.16B 58.85B 2,604B
Net income 1.84B 1.62B 1.49B 1.37B 2.59B 178B 2.63B 17.85B 7B 86.95B 6.92B 6.77B 300B 2.06B 1.81B 1.67B 1.54B 2.9B 199B 2.95B 20B 7.84B 97.42B 7.75B 7.58B 336B
Net Debt 7.41B 6.49B 6B 5.52B 10.41B 714B 10.58B 71.75B 28.13B 349B 27.81B 27.2B 1,204B 6.81B 5.97B 5.52B 5.08B 9.58B 657B 9.73B 65.98B 25.87B 321B 25.58B 25.02B 1,107B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-20 US$19.02 +0.21% 12,206,595
26-07-17 US$18.98 -0.21% 29,311,427
26-07-16 US$19.02 +1.71% 15,950,710
26-07-15 US$18.70 -0.32% 18,492,278
26-07-14 US$18.76 -2.44% 19,474,126
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.98USD
Average target price
19.75USD
Spread / Average Target
+4.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock